|
51
|
238
|
4crbA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
44
|
251
|
4djzB |
Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold |
|
59
|
228
|
4d9rA |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
55
|
237
|
4crcA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
54
|
238
|
4cr5A |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
54
|
238
|
4craA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
52
|
236
|
4d7fA |
Human fxia in complex with small molecule inhibitors. |
|
55
|
237
|
4crgA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
56
|
224
|
4dg4A |
Human mesotrypsin-s39y complexed with bovine pancreatic trypsin inhibitor (bpti) |
|
54
|
238
|
4cr9A |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
53
|
238
|
4crfA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
37
|
184
|
4dcdA |
1.6a resolution structure of poliovirus 3c protease containing a covalently bound dipeptidyl inhibitor |
|
51
|
236
|
4d7gA |
Human fxia in complex with small molecule inhibitors. |
|
53
|
238
|
4creA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
58
|
235
|
4dgjA |
Structure of a human enteropeptidase light chain variant |
|
53
|
236
|
4d76A |
Human fxia in complex with small molecule inhibitors. |
|
55
|
236
|
4crdA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
37
|
326
|
4bxsA |
Crystal structure of the prothrombinase complex from the venom of pseudonaja textilis |
|
54
|
234
|
4btuB |
Factor xa in complex with the dual thrombin-fxa inhibitor 57. |
|
16
|
131
|
4chaB |
Structure of alpha-*chymotrypsin refined at 1.68 angstroms resolution |
|
69
|
322
|
4bxwA |
Crystal structure of the prothrombinase complex from the venom of pseudonaja textilis |
|
58
|
234
|
4btiB |
Factor xa in complex with the dual thrombin-fxa inhibitor 58. |
|
63
|
257
|
4ch8B |
High-salt crystal structure of a thrombin-gpibalpha peptide complex |
|
61
|
228
|
4cbnA |
Crystal structure of complement factor d mutant r202a after conventional refinement |
|
55
|
234
|
4bttB |
Factor xa in complex with the dual thrombin-fxa inhibitor 31. |
|
69
|
258
|
4ch2B |
Low-salt crystal structure of a thrombin-gpibalpha peptide complex |
|
64
|
257
|
4bohA |
Madanins (merops i53) are cleaved by thrombin and factor xa |
|
59
|
257
|
4ax9H |
Human thrombin complexed with napsagatran, ro0466240 |
|
208
|
645
|
4b74A |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
65
|
256
|
4bakB |
Thrombin in complex with inhibitor |
|
55
|
223
|
4b2bA |
Structure of the factor xa-like trypsin variant triple-ala (tgpa) in complex with eglin c |
|
197
|
645
|
4b71A |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
181
|
791
|
4a5tS |
Structural basis for the conformational modulation |
|
209
|
645
|
4b73A |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
63
|
256
|
4baoB |
Thrombin in complex with inhibitor |
|
208
|
645
|
4b75A |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
63
|
256
|
4banB |
Thrombin in complex with inhibitor |
|
61
|
256
|
4baqB |
Thrombin in complex with inhibitor |
|
196
|
646
|
4b6fA |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
55
|
223
|
4b1tA |
Structure of the factor xa-like trypsin variant triple-ala (ta) in complex with eglin c |
|
54
|
237
|
4bnrA |
Extremely stable complex of crayfish trypsin with bovine trypsin inhibitor |
|
58
|
257
|
4ayvB |
Human thrombin - inhibitor complex |
|
202
|
646
|
4b6eA |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
62
|
256
|
4bamB |
Thrombin in complex with inhibitor |
|
55
|
223
|
4b2cA |
Structure of the factor xa-like trypsin variant triple-ala (tpa) in complex with eglin c |
|
67
|
258
|
4bahB |
Thrombin in complex with inhibitor |
|
58
|
223
|
4b2aA |
Structure of the factor xa-like trypsin variant triple-ala (tga) in complex with eglin c |
|
132
|
467
|
4asuD |
F1-atpase in which all three catalytic sites contain bound nucleotide, with magnesium ion released in the empty site |
|
211
|
645
|
4b76A |
Discovery of an allosteric mechanism for the regulation of hcv ns3 protein function |
|
61
|
257
|
4ayyB |
Human thrombin - inhibitor complex |
